106
Participants
Start Date
September 30, 2011
Primary Completion Date
March 31, 2018
Study Completion Date
May 28, 2019
pazopanib + gemcitabine
pazopanib tablets (200mg) per os, 800mg/day continuously gemcitabine IV, 2 injection per cycle
Institut Paoli Calmettes, Marseille
CHU Timone, Marseille
Centre François Baclesse, Caen
Centre G.F Leclerc, Dijon
Institut Claudius Regaud, Toulouse
Institut Bergonié, Bordeaux
Centre Val d'Aurelle Paul Lamarque, Montpellier
Institut de Cancérologie de l'Ouest/Centre René Gauducheau, Nantes Saint Herblain
Centre Alexis Vautrin, Vandœuvre-lès-Nancy
Centre Oscar Lambret, Lille
Centre Jean Perrin, Clermont-Ferrand
Centre Léon Bérard, Lyon
Institut Curie - Hôpital Claudius Regaud, Paris
Centre Henri Becquerel, Rouen
Institut Curie - Hopital René Huguenin, Saint-Cloud
Institut Gustave Roussy, Villejuif
Centre Antoine Lacassagne, Nice
UNICANCER
OTHER